Rallybio Corp

RLYB NASDAQ Santé & Biotech États-Unis US75120L1008
15.91 $
0.06 %

Rallybio Corp est centré sur le développement de médicaments pour le traitement de maladies rares.

Performance & Momentum

6 Months 158.62 %
1 Year 464.99 %
3 Years 73.02 %
5 Years 88.30 %

Similar stocks to Rallybio Corp

Anantys Community

Be the first to share your analysis on Rallybio Corp.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases